Ubix Therapeutics Inc.

1 trials Commercial sponsor

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

0 Recruiting

0 Completed trials

1 Countries active

0 Unique IMPs

N/A Results reported

Phase I

Top indications

B-cell lymphoma recurrent 1 Chronic lymphocytic leukaemia recurrent 1 Waldenstrom's macroglobulinaemia refractory 1 B-cell small lymphocytic lymphoma refractory 1 B-cell small lymphocytic lymphoma recurrent 1 Waldenstrom's macroglobulinaemia recurrent 1 B-cell lymphoma refractory 1 Chronic lymphocytic leukaemia refractory 1

All trials

1 total

Phase Ia/Ib Study of UBX-303061 in Subjects with Relapsed/Refractory B-Cell Malignancies Pending

2023-510484-35-00 Phase I 1 country

Showing 1–1 of 1 trials

← All sponsors A–Z